Aspects of Vulnerability of People Living with HIV in the Alpine Arc Region

NCT04846595 | Completed

• 1 other identifier: 20-16
• Study Type: interventional
• Target: 595
• Locations: 1 country
• Sites: 1

Brief Summary

HIV infection in France has become a chronic disease and treatment has allowed patients to increase their life expectancy. However, these promising results suffer from a very large variability within the socio-epidemiological subgroups, and life expectancy at 20 years of age is still one third lower than in the general population. Few studies of metropolitan cohorts investigated precariousness as an independent risk factor for mortality. The investigators chose to consider the vulnerability of people living with HIV (PLWHA) through the measurement of a validated French quantitative score, called EPICES ("Évaluation de la précarité et des inégalités de santé dans les centres d'examens de santé ", Evaluation of precariousness and health inequalities in health examination centers).

Conditions

HIV Infections

Outcome Measures

Primary Outcomes (1)

• Variables of vulnerability

  Evaluation of the variables associated with a state of vulnerability according to the "EPICES" scale (at a threshold of 30.17/100), among the social, demographic and medical characteristics of people living with HIV in the Alpine Arc region characteristics of people living with HIV in the Alpine Arc region

  one day

Study Arms (1)

Self questionnaire

OTHER

The study will be offered to all patients who have been treated for HIV infection for at least 6 months, during a follow-up consultation. A self questionnaire will be administered only once per patient during the usual consultation, there is no follow-up planned.

Other: self questionnaire

Interventions

self questionnaire OTHER

Evaluate the demographic variables and medical characteristics of people living with HIV in the Alpine Arc region

Self questionnaire

Eligibility Criteria

• Age: 18 Years - 99 Years
• Sex: all
• Healthy Volunteers: No
• Age Groups: Adult (18-64), Older Adult (65+)

You may qualify if:

• Any person living with HIV presenting for consultation with their infectious disease referrer.
• Patient followed for at least 6 months for their HIV infection
• Patient with undetectable or detectable HIV viral load
• Patient of legal age at the time of the study
• Patient informed of the study and having expressed no objection to the collection of health data

You may not qualify if:

• Patient opposed or unable to express opposition to participation in the study
• Patient is a minor at the time of the study
• Patient taking antiretroviral therapy for less than 6 months

Sponsors & Collaborators

• Centre Hospitalier Annecy Genevois: lead

Study Sites (1)

Ch Annecy Genevois

Pringy, Haute-Savoie, 74374, France

Location

MeSH Terms

Conditions

HIV Infections

Condition Hierarchy (Ancestors)

Blood-Borne Infections; Communicable Diseases; Infections; Sexually Transmitted Diseases, Viral; Sexually Transmitted Diseases; Lentivirus Infections; Retroviridae Infections; RNA Virus Infections; Virus Diseases; Genital Diseases; Urogenital Diseases; Immunologic Deficiency Syndromes; Immune System Diseases

Study Design

• Study Type: interventional
• Phase: not applicable
• Allocation: NA
• Masking: NONE
• Purpose: OTHER
• Intervention Model: SINGLE GROUP
• Sponsor Type: OTHER
• Responsible Party: SPONSOR

Study Record Dates

• First Submitted: April 7, 2021
• First Posted: April 15, 2021
• Study Start: February 16, 2021
• Primary Completion: October 17, 2022
• Study Completion: October 17, 2022
• Last Updated: February 13, 2025

Record last verified: 2025-02

Data Sharing

• IPD Sharing: Will not share

Locations

FR (1)